Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents
- 1 September 1989
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 12 (5), 413-420
- https://doi.org/10.1016/0732-8893(89)90112-0
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Development of in vitro susceptibility testing criteria and quality control parametersClinical Microbiology Newsletter, 1989
- In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101European Journal of Clinical Microbiology & Infectious Diseases, 1988
- Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testingDiagnostic Microbiology and Infectious Disease, 1988
- In vitro antimicrobial activity of tigemonam, a new orally administered monobactamAntimicrobial Agents and Chemotherapy, 1988
- Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality controlDiagnostic Microbiology and Infectious Disease, 1988
- Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidDiagnostic Microbiology and Infectious Disease, 1987